title: A melatonin-based fluorescence method for the measurement of mitochondrial complex III function in intact cells.
abstract: Mitochondrial complex III (MC-3) plays a pivotal role in electron transfer and oxidative phosphorylation. Impaired MC-3 functions may contribute to a variety of diseases by interrupting normal bioenergetics and increasing reactive oxygen production and oxidative stress. Currently, MC-3 function is assessed by measuring the cytochrome c reductase activity spectrophotometrically in isolated mitochondria or MC-3. The cytoplasmic microenvironment critical for mitochondrial complex functions may be depleted during these isolation processes. The development of a reliable method to measure MC-3 activities in intact cells or tissues is highly desirable. This report describes a novel fluorescence-based method to assess MC-3 functions, i.e., Qi site electron transfer, in the intact cells. Human mesangial and teratocarcinoma NT2 cells were used to demonstrate that melatonin-induced oxidation of 2',7'-dichlorodihydrofluorescein (H2 DCF) was inhibited by antimycin A, the MC-3 Qi site-specific inhibitor, but not by myxothiazol, the MC-3 Qo site-specific inhibitor, nor rotenone, the mitochondrial complex I inhibitor. These results indicate that melatonin-induced oxidation of H2 DCF is reflecting MC-3 Qi site electron transfer activities. Modifying structures of the side groups at the R3 and R5 positions of the indole ring of melatonin diminished its efficacy for inducing H2 DCF oxidation, suggesting a specific interaction of melatonin with the MC-3 Qi site. These results suggest that the fluorogenic property of melatonin-induced H2 DCF oxidation provides a MC-3 Qi site electron transfer-specific measurement in intact cells. Interestingly, using this method, the Qi site electron transfer activity in transformed or immortalized cells was found to be significantly higher than the nontransformed cells.
authors: Geriatric Research, Education and Clinical Center, Audie L Murphy Division, South Texas Veterans Health Care System, San Antonio, TX, USA; Department of Neurology, Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai, China.
authors: Jian-Liang
authors: JL
authors: Fu
authors: Hong-Mei
authors: HM
authors: Zhang
authors: Hua
authors: H
authors: Zhang
authors: Amrita
authors: A
authors: Kamat
authors: Chih-Ko
authors: CK
authors: Yeh
authors: Bin-Xian
authors: BX
authors: Zhang
mesh_terms: D000968:Antimycin A / Q000494:pharmacology; D002478:Cells, Cultured; D014450:Electron Transport Complex III / Q000037:antagonists & inhibitors / Q000378:metabolism*; D005452:Fluoresceins / Q000378:metabolism; D006801:Humans; D008550:Melatonin / Q000378:metabolism*; D008689:Methacrylates / Q000494:pharmacology; D013844:Thiazoles / Q000494:pharmacology
chemical_list: D005452:Fluoresceins; D008689:Methacrylates; D013844:Thiazoles; C065013:2',7'-dichlorodihydrofluorescein; D000968:Antimycin A; C030517:myxothiazol; D014450:Electron Transport Complex III; D008550:Melatonin
keywords: H
  2
  DCF; Qi site; cancer; electron transfer; melatonin; mitochondrial complex III
references: Science. 2006 Jun 16;312(5780):1650-3
references: 16728594
references: Front Oncol. 2012 Nov 21;2:171
references: 23181220
references: J Pineal Res. 2013 Mar;54(2):127-38
references: 23137057
references: Mol Neurodegener. 2011 Jul 26;6(1):53
references: 21791084
references: Toxicol Appl Pharmacol. 2009 Aug 15;239(1):37-45
references: 19463840
references: Stem Cells Dev. 2010 Jul;19(7):1095-107
references: 19737070
references: Am J Physiol. 1998 Aug;275(2):C367-74
references: 9688590
references: Br J Cancer. 2013 Mar 5;108(4):848-58
references: 23403820
references: J Invest Dermatol. 2013 Jul;133(7):1890-900
references: 23370535
references: J Pineal Res. 2011 Oct;51(3):338-44
references: 21615785
references: Curr Top Med Chem. 2008;8(11):954-68
references: 18673165
references: J Pineal Res. 2011 Jan;50(1):78-82
references: 20969621
references: J Pineal Res. 2001 May;30(4):243-7
references: 11339514
references: Biochem Pharmacol. 2004 Jul 15;68(2):373-81
references: 15194009
references: Mitochondrion. 2008 Mar;8(2):155-63
references: 18272433
references: IUBMB Life. 2012 Mar;64(3):231-41
references: 22279035
references: Biochem Med Metab Biol. 1994 Feb;51(1):35-42
references: 8192914
references: J Biol Chem. 2004 Nov 19;279(47):49064-73
references: 15317809
references: J Pineal Res. 2011 Aug;51(1):1-16
references: 21752095
references: Biochim Biophys Acta. 2011 Jul;1807(7):788-802
references: 21352799
references: FEBS Lett. 1997 Oct 20;416(2):175-8
references: 9369208
references: Toxicol Appl Pharmacol. 2009 Jul 15;238(2):170-7
references: 19460395
references: FEMS Yeast Res. 2008 Mar;8(2):183-92
references: 18093133
references: J Pineal Res. 2011 Aug;51(1):17-43
references: 21517957
references: In Vitro Cell Dev Biol. 1991 Sep;27A(9):707-12
references: 1717429
references: J Mol Med (Berl). 2010 Oct;88(10):993-1001
references: 20725711
references: Nature. 1998 Apr 16;392(6677):677-84
references: 9565029
references: PLoS One. 2009 Jun 26;4(6):e6048
references: 19557129
references: Antioxid Redox Signal. 2013 Oct 20;19(12):1337-55
references: 23373752
references: Mol Pharmacol. 2013 May;83(5):1007-19
references: 23444014
references: Virchows Arch B Cell Pathol Incl Mol Pathol. 1986;51(3):187-95
references: 2426861
references: N Engl J Med. 2013 Mar 14;368(11):1027-32
references: 23484829
references: Neuro Endocrinol Lett. 2011;32(5):575-87
references: 22167140